390 related articles for article (PubMed ID: 32973449)
1. MicroRNAs in Alzheimer's Disease: Function and Potential Applications as Diagnostic Biomarkers.
Wei W; Wang ZY; Ma LN; Zhang TT; Cao Y; Li H
Front Mol Neurosci; 2020; 13():160. PubMed ID: 32973449
[TBL] [Abstract][Full Text] [Related]
2. Inflamma-MicroRNAs in Alzheimer's Disease: From Disease Pathogenesis to Therapeutic Potentials.
Liang Y; Wang L
Front Cell Neurosci; 2021; 15():785433. PubMed ID: 34776873
[TBL] [Abstract][Full Text] [Related]
3. Cerebrospinal fluid microRNAs as potential biomarkers in Alzheimer's disease.
Noor Eddin A; Hamsho K; Adi G; Al-Rimawi M; Alfuwais M; Abdul Rab S; Alkattan K; Yaqinuddin A
Front Aging Neurosci; 2023; 15():1210191. PubMed ID: 37476007
[TBL] [Abstract][Full Text] [Related]
4. MicroRNAs as a New Target for Alzheimer's Disease Treatment.
Shademan B; Avci CB; Karamad V; Sogutlu F; Nourazarian A
Microrna; 2023; 12(1):3-12. PubMed ID: 36173083
[TBL] [Abstract][Full Text] [Related]
5. Alzheimer's Disease and microRNA-132: A Widespread Pathological Factor and Potential Therapeutic Target.
Zhang M; Bian Z
Front Neurosci; 2021; 15():687973. PubMed ID: 34108863
[TBL] [Abstract][Full Text] [Related]
6. Alzheimer's disease: presence and role of microRNAs.
Basavaraju M; de Lencastre A
Biomol Concepts; 2016 Aug; 7(4):241-52. PubMed ID: 27505094
[TBL] [Abstract][Full Text] [Related]
7. Insights into the mechanisms of non-coding RNAs' implication in the pathogenesis of Alzheimer's disease.
Khodayi-Shahrak M; Khalaj-Kondori M; Hosseinpour Feizi MA; Talebi M
EXCLI J; 2022; 21():921-940. PubMed ID: 36110561
[TBL] [Abstract][Full Text] [Related]
8. MicroRNAs in Alzheimer's Disease: Diagnostic Markers or Therapeutic Agents?
Angelucci F; Cechova K; Valis M; Kuca K; Zhang B; Hort J
Front Pharmacol; 2019; 10():665. PubMed ID: 31275145
[TBL] [Abstract][Full Text] [Related]
9. Secretases-related miRNAs in Alzheimer's disease: new approach for biomarker discovery.
Hajjari SN; Mehdizadeh M; Sadigh-Eteghad S; Shanehbandi D; Teimourian S; Baradaran B
Neurol Sci; 2017 Nov; 38(11):1921-1926. PubMed ID: 28791490
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA Dysregulation in Alzheimer's Disease.
Putteeraj M; Fairuz YM; Teoh SL
CNS Neurol Disord Drug Targets; 2017; 16(9):1000-1009. PubMed ID: 28782488
[TBL] [Abstract][Full Text] [Related]
11. Dysregulation and diagnostic potential of microRNA in Alzheimer's disease.
Pan Y; Liu R; Terpstra E; Wang Y; Qiao F; Wang J; Tong Y; Pan B
J Alzheimers Dis; 2016; 49(1):1-12. PubMed ID: 26484912
[TBL] [Abstract][Full Text] [Related]
12. MicroRNAs as Potential Orchestrators of Alzheimer's Disease-Related Pathologies: Insights on Current Status and Future Possibilities.
Abuelezz NZ; Nasr FE; AbdulKader MA; Bassiouny AR; Zaky A
Front Aging Neurosci; 2021; 13():743573. PubMed ID: 34712129
[TBL] [Abstract][Full Text] [Related]
13. Circulating microRNAs in Alzheimer's disease: the search for novel biomarkers.
Dorval V; Nelson PT; Hébert SS
Front Mol Neurosci; 2013; 6():24. PubMed ID: 24009553
[TBL] [Abstract][Full Text] [Related]
14. Exosomes and microRNAs: New potential therapeutic candidates in Alzheimer disease therapy.
Iranifar E; Seresht BM; Momeni F; Fadaei E; Mehr MH; Ebrahimi Z; Rahmati M; Kharazinejad E; Mirzaei H
J Cell Physiol; 2019 Mar; 234(3):2296-2305. PubMed ID: 30191975
[TBL] [Abstract][Full Text] [Related]
15. Profiling microRNA from Brain by Microarray in a Transgenic Mouse Model of Alzheimer's Disease.
Wang LL; Min L; Guo QD; Zhang JX; Jiang HL; Shao S; Xing JG; Yin LL; Liu JH; Liu R; Guo SL
Biomed Res Int; 2017; 2017():8030369. PubMed ID: 29057267
[TBL] [Abstract][Full Text] [Related]
16. NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.
Jack CR; Bennett DA; Blennow K; Carrillo MC; Dunn B; Haeberlein SB; Holtzman DM; Jagust W; Jessen F; Karlawish J; Liu E; Molinuevo JL; Montine T; Phelps C; Rankin KP; Rowe CC; Scheltens P; Siemers E; Snyder HM; Sperling R;
Alzheimers Dement; 2018 Apr; 14(4):535-562. PubMed ID: 29653606
[TBL] [Abstract][Full Text] [Related]
17. Circulating microRNAs as Biomarkers of Alzheimer's Disease: A Systematic Review.
Wu HZ; Ong KL; Seeher K; Armstrong NJ; Thalamuthu A; Brodaty H; Sachdev P; Mather K
J Alzheimers Dis; 2016; 49(3):755-66. PubMed ID: 26484928
[TBL] [Abstract][Full Text] [Related]
18. Validation of MicroRNA Biomarkers for Alzheimer's Disease in Human Cerebrospinal Fluid.
Wiedrick JT; Phillips JI; Lusardi TA; McFarland TJ; Lind B; Sandau US; Harrington CA; Lapidus JA; Galasko DR; Quinn JF; Saugstad JA
J Alzheimers Dis; 2019; 67(3):875-891. PubMed ID: 30689565
[TBL] [Abstract][Full Text] [Related]
19. Potential Roles of Exosomal MicroRNAs as Diagnostic Biomarkers and Therapeutic Application in Alzheimer's Disease.
Chen JJ; Zhao B; Zhao J; Li S
Neural Plast; 2017; 2017():7027380. PubMed ID: 28770113
[TBL] [Abstract][Full Text] [Related]
20. The Role of microRNAs in Alzheimer's Disease and Their Therapeutic Potentials.
Miya Shaik M; Tamargo IA; Abubakar MB; Kamal MA; Greig NH; Gan SH
Genes (Basel); 2018 Mar; 9(4):. PubMed ID: 29561798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
